Transitioning from Aflibercept to Biosimilar Ranibizumab in Diabetic Macular Edema (DME): (The TRANSFORM-DME Trial) a Multicenter Observational Study by Chakraborty D, Sinha TK, Maiti A, Boral SK, Das A, Mondal S, Nandi K, Bhattacharya R

Get full text

Clinical Evaluation of Faricimab in Real-World Diabetic Macular Edema in India- A Multicenter Observational Study by Chakraborty D, Das S, Maiti A, Sinha TK, Das A, Sheth J, Boral SK, Mondal S, Nandi K

Get full text

TP53-mutated myelodysplastic syndrome and acute myeloid leukemia: biology, current therapy, and future directions by Daver, NG, Maiti, A, Kadia, TM, Vyas, P, Majeti, R, Wei, AH, Garcia-Manero, G, Craddock, C, Sallman, DA, Kantarjian, HM

A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated hematologic malignancies by Lachowiez, CA, Garcia, JS, Borthakur, G, Loghavi, S, Zeng, Z, Tippett, GD, Kadia, TM, Masarova, L, Yilmaz, M, Maiti, A, Bose, P, Takahashi, K, Jabbour, E, Ravandi, F, Daver, NG, Garcia-Manero, G, Vyas, P, Kantarjian, HM, Konopleva, M, Dinardo, CD

Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma by Pouleau, B, Estoppey, C, Suere, P, Nallet, E, Laurendon, A, Monney, T, Pais Ferreira, D, Drake, A, Carretero-Iglesia, L, Macoin, J, Berret, J, Pihlgren, M, Doucey, M-A, Gudi, GS, Menon, V, Udupa, V, Maiti, A, Borthakur, G, Srivastava, A, Blein, S, Mbow, ML, Matthes, T, Kaya, Z, Edwards, C, Edwards, JR, Menoret, E, Kervoëlen, C, Pellat-Deceunynck, C, Moreau, P, Zhukovsky, E, Perro, M, Chimen, M